INFORMUS has now 20,000 patients enrolled worldwid, just 20,000 more to go!
MacOrtho is pleased to announce that the International Orthopaedic Multi-centre Study in Fracture Care (INORMUS) study has reached 50% of its target sample size. INORMUS study has successfully enrolled just over 20,000 patients across 44 sites to date. We would like to thank all collaborators for their contributions to this milestone and for their continued support in this very important study.
INORMUS is a global, prospective, multi-center, observational cohort study. The primary objective of the study is to determine the mortality, re-operation and infection rates of musculoskeletal trauma patients within 30 days post-hospital admission. The INORMUS study seeks to enroll 40,000 patients from low-middle income countries in Africa, Asia, and Latin America. The INORMUS study will provide critically important estimates of musculoskeletal trauma burden to fill ongoing knowledge gaps worldwide. Consistent with the decade of road traffic safety, we will effectively study trauma burden in LMICs, and contribute to a multinational effort to identify prognostic factors for major health outcomes following musculoskeletal injuries. Insight from INORMUS will not only inform the global burden of injuries, but drive the development of simple solutions and practical interventions to decrease deaths, major fracture complications, and improve the quality of life among those who survive.